Prospera Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-64
Closed -$4K 2177
2022
Q1
$4K Buy
+64
New +$4K ﹤0.01% 2326